Caliway Selected to Present CBL-514 Phase 2 Study Results for Dercum's Disease at World Orphan Drug Congress USA 2025
CBL-514, Caliway's novel small molecule drug, was selected for data presentation at the World Orphan Drug Congress USA 2025, highlighting its promising Phase 2 study results (CBL-0201DD) for Dercum's Disease Treatment. The Phase 2 topline results...
Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation
- Seegene to showcase a conceptual video introducing CURECA™ at ESCMID Global 2025 — a full automation system expected to cover the entire PCR workforce, from sample pre-processing to result analysis. - Designed for 24-hour, seven-days-a-week,...
FDA Watch: The Quiet Gold Rush in AI-Powered Medical Devices
Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, April 2, 2025 /PRNewswire/ -- Equity Insider News Commentary – Artificial Intelligence (AI) is quickly becoming a major force in healthcare, as use of AI...
Invitation to presentation of EQT AB's Q1 Announcement 2025
STOCKHOLM, April 2, 2025 /PRNewswire/ -- EQT AB's Q1 Announcement 2025 will be published on Wednesday 16 April 2025 at approximately 07:00 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session. The...
Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca
AI-powered model predicts EGFR mutations from H&E-stained slides, demonstrating robust performance across diverse clinical settings and helping overcome barriers to molecular testing in NSCLC SEOUL, South Korea, March 26, 2025 /PRNewswire/ --...
Early career challenges and toxic leadership - among trending topics from Talogy at SIOP Conference 2025
GLENDALE, Calif., March 25, 2025 /PRNewswire/ -- The widening gap in expectations between early career hires and organizations, combined with an increased awareness of the impact of toxic leadership, are two of the trending topics being discussed by...
FOR SALE BY EXPRESSION OF INTEREST: FREEHOLD CONSERVATION SHOPHOUSE WITH RARE F&B APPROVAL AT 350/350A TANJONG KATONG ROAD
SINGAPORE, March 25, 2025 /PRNewswire/ -- Brilliance Capital Pte. Ltd. is pleased to present an exceptional opportunity to acquire a freehold conservation two-storey shophouse with an attic at 350/350A Tanjong Katong Road. This rare offering is...
BenQ Medical Technology and Brain Navi Align Partnership to Advance Neurosurgical Robotics in China
Enhancing Precision and Innovation in Neurosurgical Robotics Across China ZHUBEI, March 20, 2025 /PRNewswire/ -- Brain Navi Biotechnology, a leading innovator in neurosurgical robotics, has announced a strategic partnership with BenQ Medical...
FOR SALE BY EXPRESSION OF INTEREST: A PORTFOLIO OF CITY STRATA OFFICE FLOORS IN THE HEART OF BUGIS AND ROCHOR, AT SIM LIM TOWER, THE BENCOOLEN AND LEE KAI HOUSE
SINGAPORE, March 20, 2025 /PRNewswire/ -- Brilliance Capital Pte. Ltd. is pleased to present The Bugis Collection, a rare investment opportunity comprising three entire office floors in prime city locations. This exclusive portfolio includes a...
SK hynix Showcases Industry-Leading Memory Technology at GTC 2025
Various memory products for AI data centers, on-device, automotive businesses on display SEOUL, South Korea, March 19, 2025 /PRNewswire/ -- SK hynix Inc. (or "the company", www.skhynix.com) announced today that it will participate in the GTC 2025, a...